Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

WOAH strengthens antimicrobial resistance standards
WOAH's International Standards are revised annually.

The expanded scope takes a One Health approach.

The World Organisation for Animal Health (WOAH) has expanded the scope of its antimicrobial resistance (AMR) standards and guidelines for the animal sector.

WOAH says that the complex issue requires a One Health approach, such as the inclusion of companion animals and environmental safeguards in their guidelines.

Although antimicrobial drugs have benefitted global health significantly over the past years, the widespread use of them has led to the emergence of drug-resistant pathogens. This AMR is threatening both animal and human health, with additional repercussions across the interconnected ecosystems.

To keep up with the challenges of combatting AMR, WOAH’s International Standards are revised annually at its General Session to ensure that they are agreed among its members and grounded in scientific research.

The decision to include companion animals in the organisations’ standards to combat AMR follows an increasing global trend of pet ownership, with over one billion companion animals being kept worldwide. This has been studied extensively, revealing evidence of a bi-directional transfer of resistant pathogens between humans and their pets.

The organisation hopes that this will not only raise awareness among its members but also, through collaboration with the World Small Animal Veterinary Association, encourage good practice among pet owners.

Environmental dimensions of AMR have also influenced WOAH’s newly expanded standards.

WOAH says that the environmental impact of antimicrobials has been previously overlooked. However it says considering the environment is of critical importance to combatting AMR.

As such, environmental risk assessments should be conducted within the pharmaceutical industry when approving veterinary medicines. In addition, manufacturers should provide instructions for the safe disposal of medicine.

Finally, WOAH has emphasised the importance of specific recommendations for the use of antimicrobial medicines. It has therefore updated its list of antimicrobial agents of veterinary importance, to align its recommendations with changes made by the World Health Organisation.

The organisation hopes that the newly expanded standards will lead to more responsible antimicrobial use across different animal health contexts.

Stephen Page, a member of the AMR Working Group, said: “This is an important step forward in the fight against the deadly threat of AMR.

“For many years there has been considerable interest in the appropriate use and stewardship of antimicrobials within the small animal community worldwide. Aligning this interest with the global standards and actions of WOAH is a crucial to unlocking the One Health potential."

WOAH's International Standards can be found here.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
Wales licenses Bluetongue vaccines for voluntary use

The Welsh government has approved three Bluetongue vaccines for emergency use in Wales.

From 1 March an online general licence will become available for the vaccines' use. They will then be obtainable on prescription and can be sold by veterinary practices.

After appropriate guidance, livestock keepers will be permitted to administer the vaccines themselves. The vaccines must be prescribed by a veterinary surgeon and detailed vaccination records must be kept for five years.

The decision comes as Bluetongue virus (BTV-3) continues to spread across England. The three vaccines are already licensed for use in England.

Richard Irvine, CVO for Wales, said: "This decision to licence these vaccines was informed by our recent risk assessment indicating that Wales is now at high risk of experiencing an incursion of Bluetongue this year.

"Our primary aim is to keep Bluetongue out of Wales through biosecurity, vigilance and safe sourcing of livestock."